263 related articles for article (PubMed ID: 27956727)
21. Community-acquired pneumonia in older patients: does age influence systemic cytokine levels in community-acquired pneumonia?
Kelly E; MacRedmond RE; Cullen G; Greene CM; McElvaney NG; O'Neill SJ
Respirology; 2009 Mar; 14(2):210-6. PubMed ID: 19272082
[TBL] [Abstract][Full Text] [Related]
22. Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response.
Bordon JM; Fernandez-Botran R; Wiemken TL; Peyrani P; Uriarte SM; Arnold FW; Rodriquez-Hernandez L; Rane MJ; Kelley RR; Binford LE; Uppatla S; Cavallazzi R; Blasi F; Aliberti S; Restrepo MI; Fazeli S; Mathur A; Rahmani M; Ayesu K; Ramirez J
Infection; 2015 Dec; 43(6):729-38. PubMed ID: 26424683
[TBL] [Abstract][Full Text] [Related]
23. Interleukin 1 receptor antagonist (IL1RA) gene polymorphism and levels associated with adverse outcome in severe community-acquired pneumonia in children: A hospital-based study in India.
Awasthi S; Yadav KK; Pandey M; Mahdi AA; Awasthi N
Pediatr Pulmonol; 2018 Sep; 53(9):1276-1283. PubMed ID: 29943912
[TBL] [Abstract][Full Text] [Related]
24. The associations of serum S100A9 with the severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study.
Liu HY; Xiang HX; Xiang Y; Xu Z; Feng CM; Fei J; Fu L; Zhao H
BMC Infect Dis; 2021 Apr; 21(1):327. PubMed ID: 33827454
[TBL] [Abstract][Full Text] [Related]
25. Biomarkers and community-acquired pneumonia: tailoring management with biological data.
Torres A; Ramirez P; Montull B; Menéndez R
Semin Respir Crit Care Med; 2012 Jun; 33(3):266-71. PubMed ID: 22718212
[TBL] [Abstract][Full Text] [Related]
26. Serum IL-27 predicts the severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study.
Xu Z; Wang XM; Cao P; Zhang C; Feng CM; Zheng L; Xu DX; Fu L; Zhao H
Int J Med Sci; 2022; 19(1):74-81. PubMed ID: 34975300
[No Abstract] [Full Text] [Related]
27. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index.
Masiá M; Gutiérrez F; Shum C; Padilla S; Navarro JC; Flores E; Hernández I
Chest; 2005 Oct; 128(4):2223-9. PubMed ID: 16236878
[TBL] [Abstract][Full Text] [Related]
28. Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia.
Esposito S; Bianchini S; Gambino M; Madini B; Di Pietro G; Umbrello G; Presicce ML; Ruggiero L; Terranova L; Principi N
BMC Pulm Med; 2016 Jul; 16(1):103. PubMed ID: 27439403
[TBL] [Abstract][Full Text] [Related]
29. Contrasting inflammatory responses in severe and non-severe community-acquired pneumonia.
Fernandez-Botran R; Uriarte SM; Arnold FW; Rodriguez-Hernandez L; Rane MJ; Peyrani P; Wiemken T; Kelley R; Uppatla S; Cavallazzi R; Blasi F; Morlacchi L; Aliberti S; Jonsson C; Ramirez JA; Bordon J
Inflammation; 2014 Aug; 37(4):1158-66. PubMed ID: 24557760
[TBL] [Abstract][Full Text] [Related]
30. The effect of age on the systemic inflammatory response in patients with community-acquired pneumonia.
van Vught LA; Endeman H; Meijvis SC; Zwinderman AH; Scicluna BP; Biesma DH; van der Poll T
Clin Microbiol Infect; 2014 Nov; 20(11):1183-8. PubMed ID: 24930498
[TBL] [Abstract][Full Text] [Related]
31. Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome.
Chien JY; Hsueh PR; Cheng WC; Yu CJ; Yang PC
Respirology; 2006 Nov; 11(6):715-22. PubMed ID: 17052299
[TBL] [Abstract][Full Text] [Related]
32. C-reactive protein and procalcitonin: As predictor biomarkers of severity and outcome in children with community-acquired pneumonia.
Yadav RK; Kumar D; Gupta A; Sharma P
Trop Doct; 2024 Jul; 54(3):262-267. PubMed ID: 38693837
[TBL] [Abstract][Full Text] [Related]
33. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A
J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
[TBL] [Abstract][Full Text] [Related]
34. Serum 8-Hydroxydeoxyguanosine Is a Potential Indicator for the Severity and Prognosis in Patients with Community-Acquired Pneumonia: A Prospective Cohort Study.
Cao LF; Cheng JY; Xu Z; Feng CM; Zhao H; Wang XM; Fu L
J Immunol; 2022 Jan; 208(2):321-327. PubMed ID: 34911771
[TBL] [Abstract][Full Text] [Related]
35. Metabolic profiles in community-acquired pneumonia: developing assessment tools for disease severity.
Ning P; Zheng Y; Luo Q; Liu X; Kang Y; Zhang Y; Zhang R; Xu Y; Yang D; Xi W; Wang K; Chen Y; An S; Gao Z
Crit Care; 2018 May; 22(1):130. PubMed ID: 29759075
[TBL] [Abstract][Full Text] [Related]
36. Plasma levels of soluble intercellular adhesion molecule-1 as a biomarker for disease severity of patients with community-acquired pneumonia.
Chang PY; Tsao SM; Chang JH; Chien MH; Hung WY; Huang YW; Yang SF
Clin Chim Acta; 2016 Dec; 463():174-180. PubMed ID: 27983998
[TBL] [Abstract][Full Text] [Related]
37. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study.
Kellum JA; Kong L; Fink MP; Weissfeld LA; Yealy DM; Pinsky MR; Fine J; Krichevsky A; Delude RL; Angus DC;
Arch Intern Med; 2007 Aug 13-27; 167(15):1655-63. PubMed ID: 17698689
[TBL] [Abstract][Full Text] [Related]
38. Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ.
Zobel K; Martus P; Pletz MW; Ewig S; Prediger M; Welte T; Bühling F;
BMC Pulm Med; 2012 Feb; 12():6. PubMed ID: 22348735
[TBL] [Abstract][Full Text] [Related]
39. Expression Levels of Interferon Regulatory Factor 5 (IRF5) and Related Inflammatory Cytokines Associated with Severity, Prognosis, and Causative Pathogen in Patients with Community-Acquired Pneumonia.
Wang X; Guo J; Wang Y; Xiao Y; Wang L; Hua S
Med Sci Monit; 2018 May; 24():3620-3630. PubMed ID: 29847542
[TBL] [Abstract][Full Text] [Related]
40. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD.
Crisafulli E; Menéndez R; Huerta A; Martinez R; Montull B; Clini E; Torres A
Chest; 2013 Apr; 143(4):1009-1017. PubMed ID: 23187314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
